Butalbital, Aspirin, Caffeine and Codeine Phosphate
- Product NDC
- 0527-1312
- 11-digit product format
- 005271312
- Labeler code
- 0527
- Product ID
- 0527-1312_b040a6d6-8f3b-4f09-825f-cf2a2fec2499
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Butalbital, Aspirin, Caffeine and Codeine Phosphate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA074951
- Marketing category
- ANDA
- Marketing start
- 1998-08-31
- Marketing end
- 0000-00-00
- Substance
- BUTALBITAL; ASPIRIN; CAFFEINE; CODEINE PHOSPHATE
- Active strength
- 50 mg/1; mg/1; mg/1; mg/1
- Pharmacologic classes
- Barbiturates [CS],Barbiturate [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0527-1312-01 | 00527131201 | 100 CAPSULE in 1 BOTTLE (0527-1312-01) | 100 capsule | 1998-08-31 | 0000-00-00 | No | No | Current |